𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Investigation of impaired carbohydrate metabolism in pediatric liver transplant recipients

✍ Scribed by Selim Gökçe; Özlem Durmaz; Coşkun Çeltik; Ayşen Aydoğan; Firdevs Baş; Ümit Türkoğlu; İlgin Özden; Semra Sökücü

Book ID
110896629
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
115 KB
Volume
13
Category
Article
ISSN
1397-3142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allograft rejection in pediatric recipie
Allograft rejection in pediatric recipients of living related liver transplants
✍ E M Alonso; J B Piper; G Echols; J R Thistlethwaite; P F Whitington 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

The purpose of this study was to compare the inci-dence and severity of rejection episodes in a group of dence and severity of rejection episodes in a group of children receiving living related orthotopic liver transchildren receiving living related orthotopic liver transplants (LRLT) versus patient

Impaired erythropoietin production in li
Impaired erythropoietin production in liver transplant recipients: The role of calcineurin inhibitors
✍ Valérie Bardet; Alcindo Pissaia Junior; Joël Coste; Carinne Lecoq-Lafon; Sandrin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Anemia is common following liver transplantation. Because cyclosporine inhibits erythropoietin (Epo) production in experimental models, we investigated whether Epo production was impaired in liver transplant recipients receiving a cyclosporine- or tacrolimus-based immunosuppressive regimen. First, s

The natural history of hepatitis C virus
The natural history of hepatitis C virus in pediatric liver transplant recipients
✍ Neal R. Barshes; Ian W. Udell; Timothy C. Lee; Christine A. O'Mahony; Saul J. Ka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients